Kommentar
Nonsense variant readthrough therapy for epidermolysis bullosa
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae137 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Martin Laimer. Beteiligte Einrichtung: Department of Dermatology and Allergology and EB House Austria, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria. Hauptthemen laut MEDLINE: Codon, Nonsense, Epidermolysis Bullosa. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Codon, NonsenseEpidermolysis BullosaFemaleHumansMaleCollagen Type VIIGenetic Therapy
Substanzen
Codon, NonsenseCOL7A1 protein, humanCollagen Type VII
Autor:innen und Institutionen
- Department of Dermatology and Allergology and EB House Austria, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Zitieren
APA
Laimer, M. (2024). Nonsense variant readthrough therapy for epidermolysis bullosa. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae137
Vancouver
Laimer M. Nonsense variant readthrough therapy for epidermolysis bullosa. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae137
BibTeX
@article{Laimer2024,
author = {Laimer, Martin},
title = {Nonsense variant readthrough therapy for epidermolysis bullosa},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae137}
}
EUVIMED